Abstract
In order to assess the levels of distress and psychosocial support needs of a high risk population, we undertook a study to look at both the objective and subjective levels of distress and the wants and needs of individuals from a high familial cancer risk population. Three hundred and eighteen individuals (160 affected, 158 unaffected) completed several distress and psychosocial needs questionnaires (including the Brief Symptom Inventory-18). Sixty key informants were also surveyed about their perspective on the support needs of this population. In the largely female (90%), largely HBOC syndrome group (approximately 90%), 20% had significant levels of generalized distress, with no significant differences between affected and unaffected individuals. Generalized distress was also not significantly different as a function of mutation status. Individuals who received inconclusive test results, however, were more likely to indicate somatic symptoms of distress. Those individuals who did not have social support were more likely to be those who had never had cancer and who either had a mutation, received inconclusive test results, or were not tested. Key informants were most likely to indicate that patients need more support. These results provide evidence for the importance of establishing regular psychosocial distress screening, including a focus on somatic symptoms, in such high risk populations.
Similar content being viewed by others
References
Armes, J. E., & Venter, D. J. (2002). The pathology of inherited breast cancer. Pathology, 34, 309–314.
Bekker, H. L., Modell, M., Bobrow, M., & Marteau, T. (1994). The impact of genetic screening for carriers of Cystic Fibrosis. Journal of Medical Genetics, 31, 364–368.
Beran, T. M., Stanton, A. L., Kwan, L., Seldon, J., Bower, J. E., Vodermaier, A., et al. (2008). The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Families, Systems and Health, 36, 107–116.
Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002a). Changes in psychological distress after cancer genetic counseling: a comparison of affected and unaffected women. British Journal of Cancer, 86, 43–50.
Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002b). No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine, 4, 353–358.
Bleiker, E. M., Hahn, D. E., & Aaronson, N. K. (2003). Psychosocial issues in cancer genetics: current status and future directions. Acta Oncológica, 42, 276–286.
Bottorff, J. L., Balneaves, L. G., Buxton, J., Ratner, P. A., McCullum, M., Chalmers, K., et al. (2000). Falling through the cracks. Women’s experiences of ineligibility for genetic testing for risk of breast cancer. Canadian Family Physician, 46, 1449–1456.
Brown, K., Moglia, D. M., & Grumet, S. (2006). Genetic counseling for breast cancer risk: general concepts, challenging themes and future directions. Breast Disease, 27, 69–96.
Brown White, D., Bonham, V. L., Jenkins, J., Stevens, N., & McBride, C. (2008). Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiology, Biomarkers & Prevention, 17, 2980–2986.
Butow, P. N., Meiser, B., Price, M., Bennett, B., Tucker, K., Davenport, T., et al. (2005). Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. Psycho-Oncology, 14, 196–203.
Carlson, L. E., Angen, M., Cullum, J., Goodey, E., Koopmans, J., Lamont, L., et al. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90, 2297–2304.
Caruso, A., Vigna, C., Maggi, G., Sega, F. M., Cognetti, F., & Savarese, A. (2008). The withdrawal from oncogenetic counseling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample. Journal of Experimental & Clinical Cancer Research, 27, 53–70.
Chen, S., & Parmigiani, G. (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology, 25, 1329–1333.
Claes, E., Evers-Kiebooms, G., Denayer, L., Decruyenaere, M., Boogaerts, A., Philippe, K., et al. (2005). Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. Journal of Genetic Counseling, 14, 349–363.
Coyne, J. C., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68, 864–874.
Crotser, C. B., & Boehmke, M. (2009). Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science. Journal of Cancer Survivorship, 3, 21–42.
Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E. D., Steel, C. M., et al. (1998). The use of videotaped information in cancer genetic counseling: a randomized evaluation study. British Journal of Cancer, 77, 830–837.
Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counseling about breast cancer risk on women’s risk perceptions and levels of distress. British Journal of Cancer, 79, 501–508.
Dagan, E., & Shochat, T. (2009). Quality of life in asymptomatic BRCA1/2 mutation carriers. Preventive Medicine, 48, 193–196.
Derogatis, L. R. (2001). Brief symptom inventory 18: Administration, scoring and procedures manual. Minneapolis: NCS Pearson Inc.
Derogatis, L. R., & Melisaratos, N. (1983). The brief symptom inventory: an introductory report. Psychological Medicine, 13, 595–605.
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974). The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behavioral Science, 19, 1–15.
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976). The SCL-90 and the MMPI: a step in the validation of a new self-report scale. The British Journal of Psychiatry, 128, 280–289.
Di Prospero, L. S., Seminsky, M., Honeyford, J., Doan, B., Franssen, E., Meschino, W., et al. (2001). Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Canadian Medical Association Journal, 164, 1005–1009.
Escobar, J., Golding, J. M., Hough, R. L., Karno, M., Burnam, M. A., & Wells, K. B. (1987). Somatization in the community: relationship to disability and use of services. American Journal of Public Health, 77, 837–840.
Esplen, M. J., Madlensky, L., Aronson, M., Rothenmund, H., Gallinger, S., Butler, K., et al. (2007). Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clinical Genetics, 72, 394–401.
Fink, P., Jensen, J., Borgquist, L., Brevik, J. I., et al. (1995). Psychiatric morbidity in primary public health care: a Nordic multicentre investigation: I. Method and prevalence of psychiatric morbidity. Acta Psychiatrica Scandinavica, 92(6), 409–418.
Fries, M. H., Hailey, B. J., Flanagan, J., & Licklider, D. (2004). Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer: report of a phase II trial. Military Medicine, 169, 411–416.
Frost, C. J., Venne, V., Cunningham, D., & Gerritsen-McKane, R. (2004). Decision Making With Uncertain Information: Learning From Women in a High Risk Breast Cancer Clinic. Journal of Genetic Counseling, 13, 221–236.
Geirdal, A. O., & Dahl, A. A. (2008). The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations. Psycho-Oncology, 17, 49–57.
Gilbar, O. (2003). Do attitude toward cancer, sense of coherence and family high risk predict more psychological distress in women referred for a breast cancer examination? Women & Health, 38, 35–46.
Godard, B., Pratte, A., Dumont, M., Simard-Lebrun, A., & Simard, J. (2007). Factors associated with an individual’s decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genetic Testing, 11, 45–54.
Goldberg, D. P., & Hillier, V. F. (1979). A scaled version of the general health questionnaire. Psychological Medicine, 9, 139–145.
Goldberg, D., & Williams, P. (1988). A users guide to the general health questionnaire. Windsor: NFER-Nelson.
Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., & Watson, M. (2004). Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Social Science & Medicine, 59, 553–565.
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10, 19–32.
Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology, 7, 402–412.
Hough, R. L., Landsverk, J. A., Stone, J. D., & Jacobson, G. R. (1982). Comparison of psychiatric screening questionnaires for primary care patients. (Final report for NIMH Contract No. 278-281-0036 [DB]).
Kash, K. M., Holland, J. C., Halper, M. S., & Miller, D. G. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute, 84, 24–30.
Kroenke, K. (2000). Somatization in primary care: it’s time for parity. General Hospital Psychiatry, 22, 141–143.
Lerman, C. E., Hughes, C., Lemon, S. J., Main, D., Snyder, C., Durham, C., et al. (1998). What you don’t know can hurt you: adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. Journal of Clinical Oncology, 16, 1650–1654.
Marteau, T. M., & Richards, M. (1996). The troubled helix: Social and psychological implications of the new human genetics. Cambridge: Cambridge University Press.
Marteau, T. M., Dundas, R., & Axworthy, D. (1997). Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychology, 16, 51–62.
Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology, 14, 1060–1074.
Meiser, B., Gaff, C., Julian-Reynier, C., Biesecker, B. B., Esplen, M. J., Vodermaier, A., et al. (2006). International perspectives on genetic counseling and testing for breast cancer risk. Breast Disease, 27, 109–125.
Mellon, S., Northhouse, L. L., & Weiss, L. K. (2006). A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nursing, 29, 120–131.
Michie, S., Smith, J. A., Senior, V., & Marteau, T. M. (2003). Understanding why negative genetic test results sometimes fail to reassure. American Journal of Medical Genetics, 119A, 340–347.
Mikkelsen, E. M., Sunde, L., Johansen, C., & Johnsen, S. P. (2009). Psychosocial consequences of genetic counseling: a population-based follow-up study. The Breast Journal, 15, 61–68.
National Comprehensive Cancer Network. (2009). NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp [On-line]. Available: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Radloff, L. S. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Riedijk, S. R., de Snoo, F. A., van Dijk, S., Bergman, W., van Haeringen, A., Silberg, S., et al. (2005). Hereditary melanoma and predictive genetic testing: why not? Psycho-Oncology, 14, 738–745.
Schlich-Bakker, K. J., & ten Kroode, H. F. J. (2006). A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Education and Counseling, 62, 13–20.
Smith, G. R., Monson, R. A., & Ray, D. C. (1986). Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Archives of Internal Medicine, 146, 69–72.
Smith, A. W., Dougall, A. L., Posluszny, D. M., Somers, T. J., Rubinstein, W. S., & Baum, A. (2008). Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psycho-Oncology, 17, 767–773.
Spielberger, C. D. (1983). State-trait anxiety inventory for adults (Form Y) [Computer software]. Palo Alto: Mind Garden.
Vadaparampil, S. T., Miree, C. A., Wilson, C., & Jacobsen, P. B. (2006). Psychosocial and behavioral impact of genetic counseling and testing. Breast Disease, 27, 98–108.
Vink, G. R., van Asperen, C. J., Devilee, P., Breuning, M. H., & Bakker, E. (2004). Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines. European Journal of Human Genetics, 13, 525–527.
Vos, J., Otten, W., van Asperen, C. J., Jansen, A., Menko, F., & Tibben, A. (2007). The counselees’ view of an unclassified variant in BRCA1/2: recall, interpretation and impact on life. Psycho-Oncology, 8, 822–830.
Wakefield, C. E., Kasparian, N. A., Meiser, B., Homewood, J., Kirk, J., & Tucker, K. (2007). Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types. Genetic Testing, 11, 401–411.
Watson, M., Lloyd, S. M., Eeles, R., Ponder, B., Easton, D., Seal, S., et al. (1996). Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting. Psycho-Oncology, 5, 233–239.
Watson, M., Duvivier, V., Wade Walsh, M., Ashley, S., Davidson, J., Papaikonomou, M., et al. (1998). Family history of breast cancer: what do women understand and recall about their genetic risk? Journal of Medical Genetics, 35, 731–738.
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., et al. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer, 79(5/6), 868–874.
Wijeratne, C., & Hickie, I. (2001). Somatic distress syndromes in later life: the need for a paradigm change—editorial. Psychological Medicine, 31, 571–576.
Zabora, J. R., BrintzenhofeSzoc, K., Jacobsen, P., Curbow, B., Piantadosi, S., Hooker, C., et al. (2001). A new psychosocial screening instrument for use with cancer patients. Psychosomatics, 42, 241–246.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.
Acknowledgements
This research was funded through the National Cancer Institute of Canada post-doctoral fellowship program with additional support from the INHERIT BRCAs project of the Canadian Institute of Health Research.
Disclosure of Interest
No conflicts of interest to be declared. The authors have full control of all primary data and agree to allow the Journal of Genetic Counseling to review said data upon request.
Author information
Authors and Affiliations
Corresponding author
Appendix A Psycho-social Support Needs Questionnaire
Appendix A Psycho-social Support Needs Questionnaire
Rights and permissions
About this article
Cite this article
Power, T.E., Robinson, J.W., Bridge, P. et al. Distress and Psychosocial Needs of a Heterogeneous High Risk Familial Cancer Population. J Genet Counsel 20, 249–269 (2011). https://doi.org/10.1007/s10897-010-9344-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-010-9344-7